EP0800405A4 - Kontinuierliche niedrigdosierte verabreichung von parathyroidhormon oder deren agonist - Google Patents

Kontinuierliche niedrigdosierte verabreichung von parathyroidhormon oder deren agonist

Info

Publication number
EP0800405A4
EP0800405A4 EP95943474A EP95943474A EP0800405A4 EP 0800405 A4 EP0800405 A4 EP 0800405A4 EP 95943474 A EP95943474 A EP 95943474A EP 95943474 A EP95943474 A EP 95943474A EP 0800405 A4 EP0800405 A4 EP 0800405A4
Authority
EP
European Patent Office
Prior art keywords
parathyro
dienne
agonist
hormone
low doses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95943474A
Other languages
English (en)
French (fr)
Other versions
EP0800405A1 (de
Inventor
Michael Chorev
Michael Rosenblatt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Center Inc filed Critical Beth Israel Deaconess Medical Center Inc
Publication of EP0800405A1 publication Critical patent/EP0800405A1/de
Publication of EP0800405A4 publication Critical patent/EP0800405A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
EP95943474A 1994-12-19 1995-12-19 Kontinuierliche niedrigdosierte verabreichung von parathyroidhormon oder deren agonist Withdrawn EP0800405A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35929394A 1994-12-19 1994-12-19
US359293 1994-12-19
PCT/US1995/016554 WO1996019246A1 (en) 1994-12-19 1995-12-19 Continuous low-dose administration of parathyroid hormone or its agonist

Publications (2)

Publication Number Publication Date
EP0800405A1 EP0800405A1 (de) 1997-10-15
EP0800405A4 true EP0800405A4 (de) 1998-11-11

Family

ID=23413202

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95943474A Withdrawn EP0800405A4 (de) 1994-12-19 1995-12-19 Kontinuierliche niedrigdosierte verabreichung von parathyroidhormon oder deren agonist

Country Status (5)

Country Link
EP (1) EP0800405A4 (de)
JP (1) JPH10511095A (de)
AU (1) AU4472896A (de)
CA (1) CA2205959A1 (de)
WO (1) WO1996019246A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US7410948B2 (en) 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5969095A (en) * 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
US6544949B1 (en) 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
DZ2873A1 (fr) * 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
CA2245903A1 (en) 1998-09-28 2000-03-28 Mcgill University Use of pex in the treatment of metabolic bone diseases
EP1325681A1 (de) 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Zusammensetzung für die Förderung des Knochenwachstums und die Erhaltung der Knochen
CN101355959B (zh) 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
EP2509996A1 (de) 2009-12-07 2012-10-17 Michigan Technological University Schwarzbär-parathyroid-hormon und verfahren zur verwendung des schwarzbär-parathyroid-hormons

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656250A (en) * 1983-08-05 1987-04-07 Toyo Jozo Kabushiki Kaisha [Nle8, Nle18, Tyr34 or Phe34 ]-h-PTH peptide derivatives
US4747825A (en) * 1984-06-29 1988-05-31 Ferring Laboratories, Inc. Apparatus and methodology for pulsed administration of growth promoting agents
EP0442671A2 (de) * 1990-02-13 1991-08-21 Takeda Chemical Industries, Ltd. Mikrokapseln mit verzögerter Wirkstoffabgabe
WO1993011786A1 (en) * 1991-12-17 1993-06-24 Procter & Gamble Pharmaceuticals, Inc. Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656250A (en) * 1983-08-05 1987-04-07 Toyo Jozo Kabushiki Kaisha [Nle8, Nle18, Tyr34 or Phe34 ]-h-PTH peptide derivatives
US4747825A (en) * 1984-06-29 1988-05-31 Ferring Laboratories, Inc. Apparatus and methodology for pulsed administration of growth promoting agents
EP0442671A2 (de) * 1990-02-13 1991-08-21 Takeda Chemical Industries, Ltd. Mikrokapseln mit verzögerter Wirkstoffabgabe
WO1993011786A1 (en) * 1991-12-17 1993-06-24 Procter & Gamble Pharmaceuticals, Inc. Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROSENBLATT M ET AL: "CHEMICAL AND BIOLOGICAL PROPERTIES OF SYNTHETIC, SULFUR-FREE ANALOGUES OF PARATHYROID HORMONE", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 251, no. 1, 10 January 1976 (1976-01-10), pages 159 - 164, XP000573183 *
See also references of WO9619246A1 *

Also Published As

Publication number Publication date
AU4472896A (en) 1996-07-10
WO1996019246A1 (en) 1996-06-27
JPH10511095A (ja) 1998-10-27
CA2205959A1 (en) 1996-06-27
EP0800405A1 (de) 1997-10-15

Similar Documents

Publication Publication Date Title
EP0746377A4 (de) Tandem-auftragekompresse für therapeutische wirkstoffe
FI951189L (fi) Serotoniiniantagonisteina toimivat N-syano-N'-pyridyyliguanidiinit
FI963679L (fi) Stabiloitu koostumus peptidien antamiseksi suun kautta
EP0601058A4 (de) Transdermale formulierungen zur prazosinverabreichung.
FR2681325B1 (fr) Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
ITMI951538A0 (it) Procedimento ed impianto per la disidratazione di foraggio particolarmente per la disidratazione dell'erba medica
EP0800405A4 (de) Kontinuierliche niedrigdosierte verabreichung von parathyroidhormon oder deren agonist
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
ZA968230B (en) Administration of biologically active material
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
FR2742153B1 (fr) Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
IT8547733A0 (it) Procedimento e dispositivo d'estrusione per la formatura di masse scorrevoli
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2753196B1 (fr) Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina
EE9400182A (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
NO306672B1 (no) N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav
FR2756564B1 (fr) Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique
EE03101B1 (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon
FR2737206B1 (fr) Derives d'oxazoloquinoleinone, leur preparation et leur application en therapeutique
FR2665443B1 (fr) Derives d'amino-4-methyl-1-tetralines, leur preparation et leur application en therapeutique.
FR2679232B1 (fr) Derives d'alpha-hydroxyimidazo [2,1-b] benzothiazole-3-acetamide, leur preparation et leur application en therapeutique.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970702

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 19980925

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000522

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000701